Business
Biofrontera Inc. to Report First Quarter 2026 Financial Results and Host a Conference Call on May 14, 2026
WOBURN, Mass., May 08, 2026 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or the “Company”), a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy (PDT), announces it will report financial results for the three months ended March 31, 2026 after the close of the U.S. financial markets on Thursday, May 14, 2026. The Company will host a conference call on Thursday, May 14, 2026 at 11:00 a.m. Eastern Time to discuss those resul
About this update from Biofrontera Inc.
[{"type":"image","alt":"Biofrontera Inc.","displaySize":"","headline":null,"caption":"Biofrontera Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":100,"url":"https://media.zenfs.com/en/globenewswire.com/2c4850cc669a3ae6c8f89e0af741c568"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/6vATQBuuc8pu4Sp7MKD9yA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE0MA--/https://media.zenfs.com/en/globenewswire.com/2c4850cc669a3ae6c8f89e0af741c568","width":300,"height":100},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/6vATQBuuc8pu4Sp7MKD9yA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE0MA--/https://media.zenfs.com/en/globenewswire.com/2c4850cc669a3ae6c8f89e0af741c568","width":300,"height":100}},"lazy":false},{"type":"text","content":"WOBURN, Mass., May 08, 2026 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or the “Company”), a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy (PDT), announces it will report financial results for the three months ended March 31, 2026 after the close of the U.S. financial markets on Thursday, May 14, 2026. The Company will host a conference call on Thursday, May 14, 2026 at 11:00 a.m. Eastern Time to discuss those results, provide a business update and answer questions.Conference Call and Webcast Information","length":592,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"style":"text-align:justify;vertical-align:middle;vertical-align:middle;","val":[{"type":"text","content":"Event:","length":6,"tagName":"p","attribs":{}}]},{"style":"text-align:justify;vertical-align:middle;vertical-align:middle;","val":[{"type":"text","content":"Biofrontera Inc. First Quarter 2026 Financial Results and Business Update Conference Call","length":89,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"text-align:justify;vertical-align:middle;vertical-align:middle;","val":[{"type":"text","content":"Date:","length":5,"tagName":"p","attribs":{}}]},{"style":"text-align:justify;vertical-align:middle;vertical-align:middle;","val":[{"type":"text","content":"Thursday, May 14, 2026","length":22,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"text-align:justify;vertical-align:middle;vertical-align:middle;","val":[{"type":"text","content":"Time:","length":5,"tagName":"p","attribs":{}}]},{"style":"text-align:justify;vertical-align:middle;vert...